Merck, Pfizer Sue Mylan Over Generic Eye Drug Application

Law360, Washington (June 17, 2013, 6:25 PM EDT) -- Pfizer Inc., Merck Sharp & Dohme Corp. and InSite Vision Inc. banded together Monday to slam Mylan Pharmaceuticals Inc. with an infringement suit in New Jersey federal court, alleging Mylan's application to market a generic version of the eye drug AzaSite violates four of their patents.

Mylan informed the companies about May 1 that it had filed an abbreviated new drug application with the U.S. Food and Drug Administration to market a generic version of the AzaSite azithromycin eye drops, which are used as a bacterial...
To view the full article, register now.